Introduction

Caproxamine is a drug which was patented as an antidepressant.

Background

Caproxamine is 2-aminoethyl-oxime derivative patented by pharmaceutical company N. V. Philips’ Gloeilampenfabrieken as the compound with pronounced action on the central nervous system in doses of 10-500 mg/day for adults.